
- Anti-CD39 monoclonal antibody IPH5201 advances to Phase 2 study in lung cancer
- Innate to receive $5M milestone payment from AstraZeneca
https://finance.yahoo.com/news/innate-pharma-announces-iph5201-phase-050000097.html
https://finance.yahoo.com/news/innate-pharma-announces-iph5201-phase-050000097.html
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations